Minimal Surviving Inoculum in Collective Antibiotic Resistance
mBio · 2023
DOI: 10.1128/mbio.02456-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Lukas Geyrhofer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Technion-Israel Institute of Technology, Haifa, Israel. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteria. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Human Frontier Science Program.
Abstract (Originalsprache)
Collective resistance occurs when bacteria work together to decrease the concentration of antibiotics in their environment, for example, by actively breaking down or modifying them. This can help bacteria survive by reducing the effective antibiotic concentration below their threshold for growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Technion-Israel Institute of Technology, Haifa, Israel.
- Wageningen University & Research, Wageningen, Netherlands.
- University of Leuven, Leuven, Belgium.
- Max Planck Institute for Evolutionary Biology, Plön, Germany.
ORCID-Profile: Lukas Geyrhofer, Philip Ruelens, Andrew D Farr, Diego Pesce, J Arjan G M de Visser, Naama Brenner
Förderung
- Human Frontier Science Program
Zitieren
APA
Geyrhofer, L., Ruelens, P., Farr, A. D., Pesce, D., de Visser, J. A. G. M., & Brenner, N. (2023). Minimal Surviving Inoculum in Collective Antibiotic Resistance. mBio. https://doi.org/10.1128/mbio.02456-22
Vancouver
Geyrhofer L, Ruelens P, Farr AD, Pesce D, de Visser JAGM, Brenner N. Minimal Surviving Inoculum in Collective Antibiotic Resistance. mBio. 2023. doi:10.1128/mbio.02456-22
BibTeX
@article{Geyrhofer2023,
author = {Geyrhofer, Lukas and Ruelens, Philip and Farr, Andrew D and Pesce, Diego and de Visser, J Arjan G M and Brenner, Naama},
title = {Minimal Surviving Inoculum in Collective Antibiotic Resistance},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.02456-22}
}
EUVIMED